Arcturus Therapeutics Holdings, Inc. (ARCT)

40.33
NASDAQ
Prev Close 39.52
Day Low/High 38.53 / 40.41
52 Wk Low/High 17.00 / 129.71
Exchange NASDAQ
Shares Outstanding 26.28B
Market Cap 1.04B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Vaccinate Your Portfolio From the Hype

Vaccinate Your Portfolio From the Hype

Let's look at the cold, hard facts around the vaccine rollout.

The Investment Angle of Covid-19

The Investment Angle of Covid-19

Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.

Stock-Specific Ideas for the Post-Fed Era of Investing

Stock-Specific Ideas for the Post-Fed Era of Investing

Make sure that your portfolio is composed of sane assets for the balance of this crazy year.

Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know

Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know

Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.

Mr. Market Has Been Dead Right on General Electric

Mr. Market Has Been Dead Right on General Electric

GE's problem can be summarized in one sentence: The company is burning cash.

Luxor Capital Loves REITs

Luxor Capital Loves REITs

The hedge fund is buying up shares of American Realty Capital Trust.